Metlife Stock Price To Sales

MET Stock

USD 86.59 1.40 1.64%

MetLife fundamentals help investors to digest information that contributes to MetLife's financial success or failures. It also enables traders to predict the movement of MetLife Stock. The fundamental analysis module provides a way to measure MetLife's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MetLife stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	0.75	0.72

Price To Sales Ratio is likely to drop to 0.72 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MetLife Company Price To Sales Analysis

MetLife's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current MetLife Price To Sales

0.83 X

Most of MetLife's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MetLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

MetLife Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for MetLife is extremely important. It helps to project a fair market value of MetLife Stock properly, considering its historical fundamentals such as Price To Sales. Since MetLife's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MetLife's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MetLife's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.82	0.4	0.51	1.0	0.24	-0.85	-0.3	0.1	0.73	0.89	0.7	0.16	0.4	0.62	0.06	0.63	0.51	-0.81	0.11	0.34	0.06	-0.15	0.23	0.17	0.11
Total Stockholder Equity	0.82		0.33	0.26	0.79	0.17	-0.58	-0.6	-0.19	0.37	0.67	0.61	0.28	0.13	0.34	0.13	0.85	0.83	-0.78	-0.1	0.62	0.11	-0.29	0.69	0.31	0.25
Net Debt	0.4	0.33		-0.31	0.4	0.33	-0.07	-0.44	0.3	0.26	0.41	-0.19	0.75	0.07	-0.18	-0.54	0.03	0.41	-0.3	-0.62	0.6	0.74	-0.69	0.29	0.31	0.61
Retained Earnings	0.51	0.26	-0.31		0.53	0.04	-0.66	0.17	0.31	0.5	0.57	0.56	-0.61	0.5	0.83	0.59	0.29	0.01	-0.26	0.71	-0.41	-0.5	0.63	-0.22	0.07	-0.62
Total Liab	1.0	0.79	0.4	0.53		0.24	-0.87	-0.26	0.13	0.76	0.89	0.7	0.14	0.42	0.64	0.05	0.59	0.46	-0.79	0.13	0.3	0.06	-0.13	0.17	0.15	0.09
Total Current Assets	0.24	0.17	0.33	0.04	0.24		-0.23	-0.31	0.53	0.17	0.43	-0.1	0.01	0.65	-0.01	0.26	-0.14	0.07	-0.17	-0.11	0.11	0.19	0.12	0.07	-0.02	-0.16
Short Term Debt	-0.85	-0.58	-0.07	-0.66	-0.87	-0.23		0.1	-0.18	-0.73	-0.87	-0.71	0.3	-0.41	-0.83	-0.3	-0.39	-0.09	0.8	-0.5	0.11	0.31	-0.25	0.16	0.16	0.2
Accounts Payable	-0.3	-0.6	-0.44	0.17	-0.26	-0.31	0.1		0.2	0.09	-0.39	-0.2	-0.39	0.02	0.05	-0.09	-0.49	-0.7	0.44	0.35	-0.58	-0.31	0.34	-0.7	-0.52	-0.37
Long Term Debt	0.1	-0.19	0.3	0.31	0.13	0.53	-0.18	0.2		0.29	0.35	-0.42	-0.25	0.56	0.2	0.1	-0.53	-0.32	0.11	0.19	-0.37	0.0	0.32	-0.41	-0.24	-0.38
Net Receivables	0.73	0.37	0.26	0.5	0.76	0.17	-0.73	0.09	0.29		0.69	0.45	0.0	0.4	0.76	0.08	0.19	0.06	-0.56	0.4	0.02	-0.1	0.09	-0.21	-0.16	0.0
Good Will	0.89	0.67	0.41	0.57	0.89	0.43	-0.87	-0.39	0.35	0.69		0.52	-0.05	0.49	0.71	0.26	0.36	0.33	-0.81	0.25	0.14	-0.09	0.07	0.07	0.13	-0.06
Short Term Investments	0.7	0.61	-0.19	0.56	0.7	-0.1	-0.71	-0.2	-0.42	0.45	0.52		-0.11	0.14	0.62	0.23	0.78	0.36	-0.57	0.33	0.08	-0.21	0.09	0.16	0.2	-0.08
Treasury Stock	0.16	0.28	0.75	-0.61	0.14	0.01	0.3	-0.39	-0.25	0.0	-0.05	-0.11		-0.26	-0.5	-0.73	0.26	0.58	-0.07	-0.87	0.85	0.84	-0.94	0.53	0.48	0.86
Intangible Assets	0.4	0.13	0.07	0.5	0.42	0.65	-0.41	0.02	0.56	0.4	0.49	0.14	-0.26		0.33	0.45	-0.05	-0.04	-0.12	0.25	-0.15	-0.13	0.38	-0.17	-0.03	-0.43
Common Stock	0.62	0.34	-0.18	0.83	0.64	-0.01	-0.83	0.05	0.2	0.76	0.71	0.62	-0.5	0.33		0.51	0.28	-0.04	-0.57	0.78	-0.33	-0.54	0.51	-0.27	-0.14	-0.4
Property Plant Equipment	0.06	0.13	-0.54	0.59	0.05	0.26	-0.3	-0.09	0.1	0.08	0.26	0.23	-0.73	0.45	0.51		0.12	-0.04	-0.19	0.68	-0.34	-0.71	0.76	0.02	-0.09	-0.63
Deferred Long Term Liab	0.63	0.85	0.03	0.29	0.59	-0.14	-0.39	-0.49	-0.53	0.19	0.36	0.78	0.26	-0.05	0.28	0.12		0.82	-0.51	-0.08	0.55	0.1	-0.26	0.7	0.47	0.23
Net Tangible Assets	0.51	0.83	0.41	0.01	0.46	0.07	-0.09	-0.7	-0.32	0.06	0.33	0.36	0.58	-0.04	-0.04	-0.04	0.82		-0.42	-0.47	0.84	0.39	-0.54	0.92	0.69	0.47
Long Term Debt Total	-0.81	-0.78	-0.3	-0.26	-0.79	-0.17	0.8	0.44	0.11	-0.56	-0.81	-0.57	-0.07	-0.12	-0.57	-0.19	-0.51	-0.42		-0.16	-0.36	0.15	0.14	-0.25	-0.02	-0.22
Capital Surpluse	0.11	-0.1	-0.62	0.71	0.13	-0.11	-0.5	0.35	0.19	0.4	0.25	0.33	-0.87	0.25	0.78	0.68	-0.08	-0.47	-0.16		-0.72	-0.79	0.89	-0.5	-0.51	-0.76
Long Term Investments	0.34	0.62	0.6	-0.41	0.3	0.11	0.11	-0.58	-0.37	0.02	0.14	0.08	0.85	-0.15	-0.33	-0.34	0.55	0.84	-0.36	-0.72		0.63	-0.79	0.8	0.54	0.73
Short Long Term Debt	0.06	0.11	0.74	-0.5	0.06	0.19	0.31	-0.31	0.0	-0.1	-0.09	-0.21	0.84	-0.13	-0.54	-0.71	0.1	0.39	0.15	-0.79	0.63		-0.72	0.34	0.35	0.59
Cash And Equivalents	-0.15	-0.29	-0.69	0.63	-0.13	0.12	-0.25	0.34	0.32	0.09	0.07	0.09	-0.94	0.38	0.51	0.76	-0.26	-0.54	0.14	0.89	-0.79	-0.72		-0.48	-0.45	-0.93
Net Invested Capital	0.23	0.69	0.29	-0.22	0.17	0.07	0.16	-0.7	-0.41	-0.21	0.07	0.16	0.53	-0.17	-0.27	0.02	0.7	0.92	-0.25	-0.5	0.8	0.34	-0.48		0.55	0.41
Capital Stock	0.17	0.31	0.31	0.07	0.15	-0.02	0.16	-0.52	-0.24	-0.16	0.13	0.2	0.48	-0.03	-0.14	-0.09	0.47	0.69	-0.02	-0.51	0.54	0.35	-0.45	0.55		0.4
Current Deferred Revenue	0.11	0.25	0.61	-0.62	0.09	-0.16	0.2	-0.37	-0.38	0.0	-0.06	-0.08	0.86	-0.43	-0.4	-0.63	0.23	0.47	-0.22	-0.76	0.73	0.59	-0.93	0.41	0.4

Click cells to compare fundamentals

MetLife Price To Sales Historical Pattern

Today, most investors in MetLife Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MetLife's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MetLife price to sales as a starting point in their analysis.

MetLife Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict MetLife

Price To Sales Ratio Over Time

MetLife Price To Sales Ratio

Price To Sales Ratio

0.72

At this time, MetLife's Price To Sales Ratio is comparatively stable compared to the past year.

Based on the latest financial disclosure, MetLife has a Price To Sales of 0.8268 times. This is 61.72% lower than that of the Insurance sector and significantly higher than that of the Financials industry. The price to sales for all United States stocks is 92.76% higher than that of the company.

MetLife Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MetLife's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MetLife could also be used in its relative valuation, which is a method of valuing MetLife by comparing valuation metrics of similar companies.

MetLife is currently under evaluation in price to sales category among its peers.

MetLife ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MetLife's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MetLife's managers, analysts, and investors.

Environmental

Governance

Social

MetLife Fundamentals

	Return On Equity	0.13
	Return On Asset	0.0058
	Profit Margin	0.05 %
	Operating Margin	0.15 %
	Current Valuation	71.41 B
	Shares Outstanding	692.42 M
	Shares Owned By Insiders	16.41 %
	Shares Owned By Institutions	75.48 %
	Number Of Shares Shorted	5.81 M
	Price To Earning	28.61 X
	Price To Book	1.85 X
	Price To Sales	0.83 X
	Revenue	66.9 B
	Gross Profit	14.89 B
	EBITDA	3.92 B
	Net Income	1.6 B
	Cash And Equivalents	20.2 B
	Cash Per Share	41.28 X
	Total Debt	18.83 B
	Debt To Equity	4.11 %
	Current Ratio	1.11 X
	Book Value Per Share	44.52 X
	Cash Flow From Operations	13.72 B
	Short Ratio	2.05 X
	Earnings Per Share	4.93 X
	Price To Earnings To Growth	0.14 X
	Target Price	91.46
	Number Of Employees	45 K
	Beta	1.04
	Market Capitalization	58.99 B
	Total Asset	687.58 B
	Retained Earnings	40.15 B
	Annual Yield	0.03 %
	Five Year Return	3.58 %
	Net Asset	687.58 B
	Last Dividend Paid	2.13

About MetLife Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze MetLife's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetLife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetLife based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC